Most Popular in:
Medical Esthetics Treatments
Medical Esthetic Technology
Posted: June 9, 2008, from the January 2007 issue of Skin Inc. magazine.
page 6 of 20
Alison Adams-Woodford, director of product development, PCA Advanced Skin Care Systems
“I feel that the next hot technology to reach the medical esthetic market will be equipment using the far-infrared ray (FIR) technology.”
Lydia Leung, president, Tinny Beauty International
“Objective analysis of the skin is accomplished with a combination of technologically advanced equipment that will take the guesswork out of choosing a skin care program for the client. These newer technologies will be used by the skin care specialist to look at the skin objectively and plan out a corrective program. The client then will better understand and participate in the program, which will lead to greater compliance and return visits. Although not inclusive, some of these technologies include:
- Simultaneous color, polarized and ultraviolet photography with computer analysis. The eye of the camera can see imperfections of the skin that the skin care specialist may miss.
- Dermascope examination of the skin. The magnified lens of the dermascope points out slight irregularities in skin moles that could indicate early developing melanomas. An early referral to your associated dermatologist may save a life.
- TEWL monitors. Transepidermal water loss detectors are available that measure insensible water loss through the skin. The accelerated loss of water through the stratum corneum will make obvious the sensitive skin of the rosacea patient. A normal water loss will uncover clients who are not using their skin care program and are not conditioned enough to develop a good result after a chemical peel.
- Lactic acid sting test. The documented level of stinging after application of a lactic acid (10%) test on the nasolabial folds will inform the skin care specialist and the client of the level of skin conditioning needed before a chemical peel, and also suggest to the specialist what level of peel will work.”
James E. Fulton Jr., MD, PhD, consultant Vivant Pharmaceuticals